Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA.
Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, Seoul, Republic of Korea.
Stat Med. 2023 Jun 15;42(13):2179-2190. doi: 10.1002/sim.9717. Epub 2023 Mar 28.
Prognostic models are useful tools for assessing a patient's risk of experiencing adverse health events. In practice, these models must be validated before implementation to ensure that they are clinically useful. The concordance index (C-Index) is a popular statistic that is used for model validation, and it is often applied to models with binary or survival outcome variables. In this paper, we summarize existing criticism of the C-Index and show that many limitations are accentuated when applied to survival outcomes, and to continuous outcomes more generally. We present several examples that show the challenges in achieving high concordance with survival outcomes, and we argue that the C-Index is often not clinically meaningful in this setting. We derive a relationship between the concordance probability and the coefficient of determination under an ordinary least squares model with normally distributed predictors, which highlights the limitations of the C-Index for continuous outcomes. Finally, we recommend existing alternatives that more closely align with common uses of survival models.
预后模型是评估患者不良健康事件风险的有用工具。在实践中,这些模型在实施前必须经过验证,以确保其具有临床意义。一致性指数(C-Index)是一种常用的统计量,用于模型验证,通常应用于二分类或生存结局变量的模型。本文总结了对 C-Index 的现有批评,并指出当应用于生存结局以及更一般的连续结局时,许多局限性被放大了。我们提出了几个例子,说明了在实现与生存结局的高一致性方面所面临的挑战,并认为在这种情况下,C-Index 通常不具有临床意义。我们推导出了在具有正态分布预测变量的普通最小二乘模型下,一致性概率与决定系数之间的关系,这突出了 C-Index 对于连续结局的局限性。最后,我们推荐了与生存模型的常见用法更紧密一致的现有替代方法。